Urokinase from human urine
≥85%, potency ≥75,000 IU/mg, specific activity 100,000 IU/mg
- Product Code: 98906
Alias:
Urokinase; U-plasminogen activator
CAS:
9039-53-6
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | 232-917-9 | MDL Number: | MFCD00132566 |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Urokinase is widely used in the medical field as a thrombolytic agent to dissolve blood clots. It is particularly effective in treating conditions like pulmonary embolism, deep vein thrombosis, and acute myocardial infarction. By activating plasminogen to plasmin, it breaks down fibrin clots, restoring blood flow in blocked vessels. It is also utilized in catheter clearance to prevent occlusion in intravenous lines. In research, urokinase is employed to study cell migration, tissue remodeling, and cancer metastasis due to its role in extracellular matrix degradation. Its application in clinical settings is carefully monitored due to the risk of bleeding complications.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to light yellow powder |
| pH1 mgml | 4.0-7.5 |
| ENDOTOXIN | 2 EU/20,000IU Urokinase |
| POTENCY | 75,000 IU/mg |
| HIV III | Negative |
| HCV antibodies | Negative |
| HBS-AG | Negative |
| Molecular fractions | N.L.T 85 % of the urokinase (M.W. 54000) |
| SPECIFIC ACTIVITY | N.L.T 100,000 IU/mg |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿4,980.00 |
+
-
|
| 0.010 | 10-20 days | ฿33,000.00 |
+
-
|
| 0.050 | 10-20 days | ฿132,000.00 |
+
-
|
Urokinase from human urine
Urokinase is widely used in the medical field as a thrombolytic agent to dissolve blood clots. It is particularly effective in treating conditions like pulmonary embolism, deep vein thrombosis, and acute myocardial infarction. By activating plasminogen to plasmin, it breaks down fibrin clots, restoring blood flow in blocked vessels. It is also utilized in catheter clearance to prevent occlusion in intravenous lines. In research, urokinase is employed to study cell migration, tissue remodeling, and cancer metastasis due to its role in extracellular matrix degradation. Its application in clinical settings is carefully monitored due to the risk of bleeding complications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :